Trial Profile
A retrospective, single-centre study to evaluate efficacy of pirfenidone in the treatment of idiopathic pulmonary fibrosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2017
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Adverse reactions; Therapeutic Use
- 17 Feb 2017 New trial record